PK/PD models in antibacterial development. - Wikidata - wikimedia - TriplyDB

PK/PD models in antibacterial development.

PK/PD models in antibacterial development.

http://www.wikidata.org/entity/Q37325658

about

Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.The Effects of Levofloxacin on Testis Tissue and Spermatogenesis in Rat The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies.Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.Microtechnology-Based Multi-Organ Models.LC-MS/MS determination of colistin in Mueller-Hinton broth for in vitro pharmacodynamic studies.In vitro simulation of in vivo pharmacokinetic model with intravenous administration via flow rate modulation.Statistical considerations associated with a comprehensive regulatory framework to address the unmet need for new antibacterial therapies.Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.

P2860

Q36083619-7B567EC9-4A2C-4648-8D35-544E8CB4C771 Q36761194-F6252B49-2872-4750-874C-2FB35669FB59 Q36932080-14D29A7E-6E4C-4128-9B40-A2902CCE8B81 Q38420688-F0F6EC8C-FBC9-4A6B-A97A-54D31E8C290B Q40657200-47097E9F-EC00-4605-B39C-65E84D2EB6D0 Q41704262-D3F655DB-2242-4879-9181-60F491A2D5C3 Q45281920-1B5D1CDB-2C89-4AB6-8D8D-2BECDDFA60F4 Q51018579-FE367852-6741-4275-87D6-F43D24383C96 Q51079236-922F505B-AE2C-41E2-A389-0578D9455B81 Q51736541-B8953529-9A95-4718-8BF4-C3FB90085A96

P2860

PK/PD models in antibacterial development.

http://www.wikidata.org/entity/Q37325658

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PK/PD models in antibacterial development.

@en

PK/PD models in antibacterial development.

@nl

type

label

PK/PD models in antibacterial development.

@en

PK/PD models in antibacterial development.

@nl

prefLabel

PK/PD models in antibacterial development.

@en

PK/PD models in antibacterial development.

@nl

P1433

Q37325658-03A94CA3-B656-4F4B-98F4-44F491689021

P1476

Q37325658-41A12534-DB78-4EC2-80A9-285278104A46

P2093

Q37325658-6408898D-B78A-45F5-9D6C-7E799950631B

Q37325658-6C213B6D-AF06-4CA9-AF3B-DFCC7F82AAAA

Q37325658-D2628D3F-EC2A-4FD2-B807-F8F912382D19

P2860

Q37325658-06099893-5B7D-49E6-8CA5-A53E76F62AC3

Q37325658-145D9567-89B7-49A4-A183-5176E336F49E

Q37325658-1BD6703E-DB89-43C8-AAAD-EE69E9E82AA4

Q37325658-1CF9F222-2BF2-4E07-B8BB-1F71567AD7F2

Q37325658-276B6B2C-722A-4881-AD0F-17EDE80B2845

Q37325658-2BCD2C5D-E646-4DFC-A4A3-2072851E8F20

Q37325658-301309BA-DAA3-4C5C-ACB1-2FD95AAE91DE

Q37325658-34AD8EC9-AAD1-4C30-94B5-ADC20248D3D3

Q37325658-34CA4388-696B-4618-820A-EA31538D43CA

Q37325658-3D0BD274-BB58-4BAF-B594-99761CD9F11E

P304

Q37325658-60933CD5-1003-4D78-B140-2D546BE925B2

P31

Q37325658-0519C937-A571-4A15-9106-75C5A6AF5322

P356

Q37325658-A8FF806E-2D94-44D5-A3F6-E17FB105DFBF

P433

Q37325658-07F6D636-4C5C-4F61-9244-F17F5BB16E7E

P478

Q37325658-F82BE8B2-DC9A-44DC-89D3-9E3F509EF0AE

P50

Q37325658-19CDC008-4648-455F-AD3B-AB7432AA6723

Q37325658-E0ACF7A8-379E-4A82-BC14-4CA580B6974D

P577

Q37325658-6E27F0D2-AA54-4CE2-AD12-97AF3F37B211

P5875

Q37325658-E71F491E-E816-41D8-861A-8EE09AB16585

P698

Q37325658-8C89FBCE-C3DC-42C3-8BC8-4DD8F0B81FBC

P932

Q37325658-CB46BEE4-8213-4A79-9C4A-6271E49180C2

P356

J.MIB.2013.06.010

P1433

Current Opinion in Microbiology

P1476

PK/PD models in antibacterial development

@en

P2093

Jaime Lora-Tamayo

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Phillip J Bergen

http://www.w3.org/2001/XMLSchema#string

P2860

Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model

Antibiotic resistance of bacteria in biofilms

Animal models of external traumatic wound infections

An in vivo polymicrobial biofilm wound infection model to study interspecies interactions

Correlated biofilm imaging, transport and metabolism measurements via combined nuclear magnetic resonance and confocal microscopy.

The use of drip flow and rotating disk reactors for Staphylococcus aureus biofilm analysis.

The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.

Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model.

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.

P304

573-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MIB.2013.06.010

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Cornelia Barbara Landersdorfer

P577

2013-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

250923314

http://www.w3.org/2001/XMLSchema#string

P698

23871724

http://www.w3.org/2001/XMLSchema#string

P932

3834155

http://www.w3.org/2001/XMLSchema#string